Risk–Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults-Reference-Cited by-同舟云学术

Risk–Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults

Published:2017-03 Issue:1 Volume:6 Page:53-61
ISSN:2156-5333
Container-title:Journal of Adolescent and Young Adult Oncology
language:en
Short-container-title:Journal of Adolescent and Young Adult Oncology

Author:

Guzauskas Gregory F.¹,Villa Kathleen F.²,Vanhove Geertrui F.²,Fisher Vicki L.²,Veenstra David L.¹

Affiliation:

1. Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, Seattle, Washington.

2. Jazz Pharmaceuticals, Palo Alto, California.

Publisher

Mary Ann Liebert Inc

Subject

Oncology,Pediatrics, Perinatology, and Child Health

Link

http://www.liebertpub.com/doi/pdf/10.1089/jayao.2016.0049

Reference33 articles.

1. Treatment of Acute Lymphoblastic Leukemia in Adolescents and Young Adults

2. The biology and therapy of adult acute lymphoblastic leukemia

3. Clinical characteristics, biologic features and outcome for young adult patients with acute lymphoblastic leukaemia

4. Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel

5. Clinical Significance of Cytogenetic Abnormalities in Adult Acute Lymphoblastic Leukemia

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The current treatment approach to adolescents and young adults with acute lymphoblastic leukemia (AYA-ALL): challenges and considerations;Expert Review of Anticancer Therapy;2022-07-12

2. Optimizing use of L-asparaginase–based treatment of adults with acute lymphoblastic leukemia;Blood Reviews;2021-11

3. New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: Recent advances;Hematological Oncology;2019-10-21

4. Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD vs. pediatric-inspired regimens;American Journal of Hematology;2018-09-03

5. Recent Developments in Adolescent and Young Adult (AYA) Acute Lymphoblastic Leukemia;Current Hematologic Malignancy Reports;2018-02-14